CardioVascular and Interventional Radiology最新文献

筛选
英文 中文
In Vivo Feasibility of Arterial Embolization with a New Permanent Agar-agar-Based Agent. 使用新型永久性琼脂琼脂制剂进行动脉栓塞的体内可行性研究
IF 2.8 3区 医学
CardioVascular and Interventional Radiology Pub Date : 2025-02-01 Epub Date: 2024-10-15 DOI: 10.1007/s00270-024-03877-9
Thibault Agripnidis, Alexis Ruimy, Julien Panneau, Johanna Nguyen, Vincent Nail, Farouk Tradi, Thierry Marx, Aurélie Haffner, Pauline Brige, Raphaël Haumont, Benjamin Guillet, Vincent Vidal
{"title":"In Vivo Feasibility of Arterial Embolization with a New Permanent Agar-agar-Based Agent.","authors":"Thibault Agripnidis, Alexis Ruimy, Julien Panneau, Johanna Nguyen, Vincent Nail, Farouk Tradi, Thierry Marx, Aurélie Haffner, Pauline Brige, Raphaël Haumont, Benjamin Guillet, Vincent Vidal","doi":"10.1007/s00270-024-03877-9","DOIUrl":"10.1007/s00270-024-03877-9","url":null,"abstract":"<p><strong>Purpose: </strong>Evaluate the safety and efficacy of an eco-friendly permanent agar-agar-based embolization agent (ABEA) (EmboBio®) for intra-arterial use.</p><p><strong>Materials and methods: </strong>Six pigs embolized with one ABEA torpedo (6 lower polar renal and 6 lumbar arteries) and one coil (6 lower polar renal and 6 lumbar arteries). Technical success was defined as a complete occlusion with no residual flow in DSA. Short-term endpoints included safety (non-targeted embolization), ease of use (embolization preparation time, occlusion time), and DSA controls at day 7, month 1, and month 3. Tissue reaction was assessed via [18F]-FDG PET/CT at month 2 and histological study at month 3.</p><p><strong>Results: </strong>ABEA torpedoes achieved immediate and persistent occlusion at month 3 for all kidney and lumbar embolizations (n = 12/12). Control coils had technical success for 12/12, with a persistent occlusion at month 3 for 2/12. No off-target embolization occurred. ABEA torpedoes demonstrate faster occlusion (ABEA: 6 ± 4 s; coils: 427 ± 469 s; p = 0.0022, n = 12) and preparation times (ABEA: 96.9 1 ± 23 s; coils: 150.33 ± 58 s; p = 0.0432, n = 12) after device placement than coil. No significant difference in inflammation between ABEA and coil groups at month 2 (ABEA: 3.35e<sup>-6</sup> ± 1.7e<sup>-6</sup>%ID/mm<sup>3</sup>; coils: 2.24e<sup>-6</sup> ± 8.5e<sup>-7</sup>%ID/mm3; p = 0.5) on PET imaging. These results were confirmed by histological analysis at month 3.</p><p><strong>Conclusion: </strong>Permanent dry foam torpedo comprising agar-agar is effective for arterial embolization. In animal model, one ABEA torpedo demonstrates a faster and more persistent occlusion than one fiber coil.</p><p><strong>Levels of evidence: </strong>Not applicable.</p>","PeriodicalId":9591,"journal":{"name":"CardioVascular and Interventional Radiology","volume":" ","pages":"258-264"},"PeriodicalIF":2.8,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142458733","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Do We Need Level I Evidence for a Well-Functioning Intervention? 我们是否需要一级证据来证明有效的干预措施?
IF 2.8 3区 医学
CardioVascular and Interventional Radiology Pub Date : 2025-02-01 Epub Date: 2024-12-18 DOI: 10.1007/s00270-024-03944-1
Stevo Duvnjak
{"title":"Do We Need Level I Evidence for a Well-Functioning Intervention?","authors":"Stevo Duvnjak","doi":"10.1007/s00270-024-03944-1","DOIUrl":"10.1007/s00270-024-03944-1","url":null,"abstract":"","PeriodicalId":9591,"journal":{"name":"CardioVascular and Interventional Radiology","volume":" ","pages":"182-183"},"PeriodicalIF":2.8,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142853096","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Venous Arterialization-A New Frontier for No-Option Chronic Limb-Threatening Ischemia. 静脉动脉化——无可选择的慢性肢体缺血治疗的新领域。
IF 2.8 3区 医学
CardioVascular and Interventional Radiology Pub Date : 2025-02-01 Epub Date: 2025-01-09 DOI: 10.1007/s00270-024-03959-8
Mehdi H Shishehbor, Ashkan Yahyavi
{"title":"Venous Arterialization-A New Frontier for No-Option Chronic Limb-Threatening Ischemia.","authors":"Mehdi H Shishehbor, Ashkan Yahyavi","doi":"10.1007/s00270-024-03959-8","DOIUrl":"10.1007/s00270-024-03959-8","url":null,"abstract":"","PeriodicalId":9591,"journal":{"name":"CardioVascular and Interventional Radiology","volume":" ","pages":"251-252"},"PeriodicalIF":2.8,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142945128","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comment on "A Meta-Analysis and Meta-Regression of Embolisation Outcomes of Pulmonary Arteriovenous Malformations".
IF 2.8 3区 医学
CardioVascular and Interventional Radiology Pub Date : 2025-02-01 Epub Date: 2025-01-23 DOI: 10.1007/s00270-025-03962-7
Shubham Kumar, Ahmad Neyazi, Rachana Mehta, Ranjana Sah
{"title":"Comment on \"A Meta-Analysis and Meta-Regression of Embolisation Outcomes of Pulmonary Arteriovenous Malformations\".","authors":"Shubham Kumar, Ahmad Neyazi, Rachana Mehta, Ranjana Sah","doi":"10.1007/s00270-025-03962-7","DOIUrl":"10.1007/s00270-025-03962-7","url":null,"abstract":"","PeriodicalId":9591,"journal":{"name":"CardioVascular and Interventional Radiology","volume":" ","pages":"180-181"},"PeriodicalIF":2.8,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143028039","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Smartphone Technology for Applications in Image-Guided Minimally Invasive Interventional Procedures. 智能手机技术在图像引导微创介入手术中的应用。
IF 2.8 3区 医学
CardioVascular and Interventional Radiology Pub Date : 2025-02-01 Epub Date: 2024-12-16 DOI: 10.1007/s00270-024-03925-4
Katerina Lee, Pournika Muniyandi, Ming Li, Laetitia Saccenti, Anna Christou, Sheng Xu, Bradford J Wood
{"title":"Smartphone Technology for Applications in Image-Guided Minimally Invasive Interventional Procedures.","authors":"Katerina Lee, Pournika Muniyandi, Ming Li, Laetitia Saccenti, Anna Christou, Sheng Xu, Bradford J Wood","doi":"10.1007/s00270-024-03925-4","DOIUrl":"10.1007/s00270-024-03925-4","url":null,"abstract":"<p><p>Smartphones contain powerful and enabling technology components that can be re-applied toward procedural tasks commonly used in everyday clinical image-guided therapies and minimally invasive procedures that use three-dimensional information and feedback during procedures. Smartphone applications are a relatively young field of research that have potential in interventional radiology (IR) toward improvement of accuracy and standardization for needle-based procedures like biopsy and ablation. This review explores the adaptation of smartphones' built-in sensors for virtual and augmented reality uses in IR. The ergonomic advantages and translational hurdles and limitations are reviewed, outlining the potential future developmental pathway of smartphones in IR.</p>","PeriodicalId":9591,"journal":{"name":"CardioVascular and Interventional Radiology","volume":" ","pages":"142-156"},"PeriodicalIF":2.8,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11790737/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142833920","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Transarterial Radioembolisation with Y90 Resin Microspheres and the Effect of Reimbursement Criteria in France: Final Results of the CIRT-FR Prospective Observational Study. Y90树脂微球经动脉放射栓塞和法国报销标准的影响:CIRT-FR前瞻性观察研究的最终结果。
IF 2.8 3区 医学
CardioVascular and Interventional Radiology Pub Date : 2025-02-01 Epub Date: 2025-01-14 DOI: 10.1007/s00270-024-03955-y
M Ronot, R Loffroy, D Arnold, M Greget, C Sengel, J B Pinaquy, O Pellerin, G Maleux, B Peynircioglu, J P Pelage, N Schaefer, B Sangro, N de Jong, B Zeka, M Urdaniz, T Helmberger, V Vilgrain
{"title":"Transarterial Radioembolisation with Y90 Resin Microspheres and the Effect of Reimbursement Criteria in France: Final Results of the CIRT-FR Prospective Observational Study.","authors":"M Ronot, R Loffroy, D Arnold, M Greget, C Sengel, J B Pinaquy, O Pellerin, G Maleux, B Peynircioglu, J P Pelage, N Schaefer, B Sangro, N de Jong, B Zeka, M Urdaniz, T Helmberger, V Vilgrain","doi":"10.1007/s00270-024-03955-y","DOIUrl":"10.1007/s00270-024-03955-y","url":null,"abstract":"<p><strong>Purpose: </strong>This analysis of the CIRSE Registry for SIR-Spheres Therapy in France, CIRT-FR, reports on real-world outcomes of transarterial radioembolisation (TARE) with Y90 resin microspheres for hepatocellular carcinoma (HCC) and colorectal cancer liver metastases (CRLM) patients in France, focusing on safety, effectiveness and health-related quality of life (HRQoL). Results on patients treated based on national reimbursement criteria are discussed here.</p><p><strong>Methods: </strong>Prospective, multicentre, observational study of HCC and CRLM patients treated between August 2017 and July 2020 with TARE Y90 resin microspheres. Patients were assigned to different analysis groups based on reimbursement recommendations. Follow-up period was at least 24 months with patient data collected every 3 months.</p><p><strong>Results: </strong>In total, 252 (193 HCC, 59 CRLM) patients of CIRT-FR were included in the analysis. No differences in effectiveness, safety and HRQoL were found between analysis groups based on reimbursement recommendations. Median overall survival for HCC and CRLM was 19.0 (95% CI, 16.1-22.4) and 10.8 (95% CI, 8.0-13.5) months, respectively. Serious procedure-related adverse events occurred in 13% of the patients. HRQoL generally remained stable, with some fluctuations in function scores and symptoms.</p><p><strong>Conclusion: </strong>In our cohorts, patients performed similarly regarding clinical outcomes irrespective of their analysis group based on reimbursement recommendations. Our results suggest that instead of restrictive reimbursement criteria, more decision-making power in selecting suitable patient groups could be given to multidisciplinary tumour boards. Results confirm that TARE with Y90 resin microspheres is an effective and safe treatment for liver cancer, with maintained HRQoL in most patients.</p>","PeriodicalId":9591,"journal":{"name":"CardioVascular and Interventional Radiology","volume":" ","pages":"205-220"},"PeriodicalIF":2.8,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11790776/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142982850","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Percutaneous Gallstone Extraction Through Midbody Access to the Gallbladder Using a Cleaner XT Rotational Thrombectomy Device: A Case Report. 使用 Cleaner XT 旋转血栓切除装置,经皮从躯干中部进入胆囊取出胆结石:病例报告。
IF 2.8 3区 医学
CardioVascular and Interventional Radiology Pub Date : 2025-02-01 Epub Date: 2024-11-11 DOI: 10.1007/s00270-024-03903-w
Preethi Jagannath, Jee Hyuk Byun, Junaid Raja
{"title":"Percutaneous Gallstone Extraction Through Midbody Access to the Gallbladder Using a Cleaner XT Rotational Thrombectomy Device: A Case Report.","authors":"Preethi Jagannath, Jee Hyuk Byun, Junaid Raja","doi":"10.1007/s00270-024-03903-w","DOIUrl":"10.1007/s00270-024-03903-w","url":null,"abstract":"","PeriodicalId":9591,"journal":{"name":"CardioVascular and Interventional Radiology","volume":" ","pages":"267-269"},"PeriodicalIF":2.8,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142615378","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Correction to: Performance of an Anti-Phase Technology-Powered Microwave Ablation System on Ex Vivo Liver, Lung and Kidney: Analysis of Temperature Trend, Ablation Size and Sphericity.
IF 2.8 3区 医学
CardioVascular and Interventional Radiology Pub Date : 2025-01-28 DOI: 10.1007/s00270-025-03970-7
Pouya Namakshenas, Tommaso Arcaini, Benedetta Cesare, Alessandro Dorato, Elena Durante, Milena Ricci, Domiziana Santucci, Paola Saccomandi, Eliodoro Faiella
{"title":"Correction to: Performance of an Anti-Phase Technology-Powered Microwave Ablation System on Ex Vivo Liver, Lung and Kidney: Analysis of Temperature Trend, Ablation Size and Sphericity.","authors":"Pouya Namakshenas, Tommaso Arcaini, Benedetta Cesare, Alessandro Dorato, Elena Durante, Milena Ricci, Domiziana Santucci, Paola Saccomandi, Eliodoro Faiella","doi":"10.1007/s00270-025-03970-7","DOIUrl":"https://doi.org/10.1007/s00270-025-03970-7","url":null,"abstract":"","PeriodicalId":9591,"journal":{"name":"CardioVascular and Interventional Radiology","volume":" ","pages":""},"PeriodicalIF":2.8,"publicationDate":"2025-01-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143051610","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Revisiting Triple Therapy for HCC: Progress in Survival Outcomes in Patients with Hepatic Vein and/or IVC Tumor Thrombus.
IF 2.8 3区 医学
CardioVascular and Interventional Radiology Pub Date : 2025-01-27 DOI: 10.1007/s00270-025-03967-2
Elif Can
{"title":"Revisiting Triple Therapy for HCC: Progress in Survival Outcomes in Patients with Hepatic Vein and/or IVC Tumor Thrombus.","authors":"Elif Can","doi":"10.1007/s00270-025-03967-2","DOIUrl":"https://doi.org/10.1007/s00270-025-03967-2","url":null,"abstract":"","PeriodicalId":9591,"journal":{"name":"CardioVascular and Interventional Radiology","volume":" ","pages":""},"PeriodicalIF":2.8,"publicationDate":"2025-01-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143051664","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Minimally Invasive Treatment of Aneurysmal Bone Cysts with Gelified Ethanol (DiscoGel®): Evaluation of Feasibility, Safety, and Efficacy.
IF 2.8 3区 医学
CardioVascular and Interventional Radiology Pub Date : 2025-01-27 DOI: 10.1007/s00270-025-03963-6
Valentin Gineys, Rémi Grange, Nicolas Stacoffe, Sylvain Bertholon, Hassan Al Khoury Salem, Elie Haddad, Claire Boutet, Sylvain Grange
{"title":"Minimally Invasive Treatment of Aneurysmal Bone Cysts with Gelified Ethanol (DiscoGel®): Evaluation of Feasibility, Safety, and Efficacy.","authors":"Valentin Gineys, Rémi Grange, Nicolas Stacoffe, Sylvain Bertholon, Hassan Al Khoury Salem, Elie Haddad, Claire Boutet, Sylvain Grange","doi":"10.1007/s00270-025-03963-6","DOIUrl":"https://doi.org/10.1007/s00270-025-03963-6","url":null,"abstract":"<p><strong>Introduction: </strong>Aneurysmal bone cysts are locally aggressive bone lesions. The aim of this study was to evaluate safety and effectiveness of radio-opaque gelified ethanol sclerotherapy in treating primary aneurysmal bone cyst.</p><p><strong>Materials and methods: </strong>In this single-center, retrospective study (January 1st, 2012, to June 30th, 2024), 32 patients with primary aneurysmal bone cysts were treated with percutaneous sclerotherapy using radio-opaque gelified ethanol at various skeletal sites. Of these, 27 patients were included in the analysis, 5 patients were excluded due to follow-up of less than 12 months. The primary outcome measure was the safety of the procedures. Secondary outcomes measures included clinical success, defined as the absence of post-sclerotherapy fractures or the need for surgical revision, and radiological success, determined by the conversion of an active or aggressive aneurysmal bone cyst to inactive, according to Campanacci's classification.</p><p><strong>Results: </strong>No major complications related to the procedure were observed. One minor complication (3.7%) was reported: One local collection resolved with antibiotic therapy. The remaining patients showed favorable clinical and radiological outcomes. No fractures were recorded after sclerotherapy. Surgical revision for progressive recurrence was necessary in 2 cases (7.4%). Aneurysmal bone cyst becoming inactive in 21 of 27 (77.8%) patients after 12 months, 13 of 14 (92.8%) patients after 24 months, and 7 of 7 (100%) and 5 of 5 (100%) patients after more than 36 and 48 months, respectively.</p><p><strong>Conclusion: </strong>Radio-opaque gelified ethanol sclerotherapy offers a safe, effective, and minimally invasive treatment for primary aneurysmal bone cyst. It may be considered a first-line approach, similar to other sclerotherapy methods, potentially avoiding the need for invasive surgery as an initial treatment option.</p>","PeriodicalId":9591,"journal":{"name":"CardioVascular and Interventional Radiology","volume":" ","pages":""},"PeriodicalIF":2.8,"publicationDate":"2025-01-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143051660","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信